Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
Menu Close

Monthly Archives: February 2020

  1. Home>
  2. 2020>
  3. February
Read more about the article Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA

Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA

  • Post author:admin
  • Post published:2020-02-14
  • Post category:2020

NEW YORK and SYDNEY, Australia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research,…

Continue ReadingBeroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA
Read more about the article Beroni Group looking to up-list to the Nasdaq

Beroni Group looking to up-list to the Nasdaq

  • Post author:admin
  • Post published:2020-02-05
  • Post category:2020

Beroni Group Inc (OTCQX:BNIGF ) (NSX:BTG) CEO Jacky Zhang sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Australian-based company currently has four core…

Continue ReadingBeroni Group looking to up-list to the Nasdaq

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (1)

What’s New

  • Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit
  • Wish You Happy New Year!
  • Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
  • Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association
  • Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu